<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Twin pregnancy: Routine prenatal care</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Twin pregnancy: Routine prenatal care</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Twin pregnancy: Routine prenatal care</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen T Chasen, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Deborah Levine, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lynn L Simpson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3591024190"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Many aspects of routine prenatal care and counseling of patients with twin pregnancies are the same as in singleton pregnancies (see  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a> and  <a class="medical medical_review" href="/z/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a> and  <a class="medical medical_review" href="/z/d/html/112420.html" rel="external">"Prenatal care: Patient education, health promotion, and safety of commonly used drugs"</a>). However, twin pregnancy is associated with higher rates of almost every potential complication of singleton pregnancy, with the exceptions of postterm pregnancy and macrosomia, and it is also associated with some unique complications. For this reason, some authorities have proposed specialized antenatal care clinics to address the specific needs of patients with twins; however, these clinics have not been proven to improve birth outcomes compared with standard care, albeit data from randomized trials are sparse [<a href="#rid1">1</a>].</p><p>This topic will review our approach to routine prenatal care of patients with twin pregnancies. This approach is generally consistent with recommendations of major medical organizations worldwide (see <a class="local">'Society guideline links'</a> below). Other important issues related to twin pregnancy are reviewed in detail separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6821.html" rel="external">"Twin pregnancy: Overview"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/131147.html" rel="external">"Twin pregnancy: Management of pregnancy complications"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4467.html" rel="external">"Twin pregnancy: Labor and delivery"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6766.html" rel="external">"Monoamniotic twin pregnancy (including conjoined twins)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6789.html" rel="external">"Twin-twin transfusion syndrome: Screening, prevalence, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6793.html" rel="external">"Twin-twin transfusion syndrome: Management and outcome"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/120803.html" rel="external">"Selective fetal growth restriction in monochorionic twin pregnancies"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/130852.html" rel="external">"Twin anemia-polycythemia sequence (TAPS)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6771.html" rel="external">"Multifetal gestation: Approach to delayed-interval delivery"</a>.)</p><p></p><p class="headingAnchor" id="H2786921669"><span class="h1">DIET, SUPPLEMENTS, AND PHYSICAL ACTIVITY</span></p><p class="headingAnchor" id="H1323623986"><span class="h2">Gestational weight gain</span><span class="headingEndMark"> — </span>The National Academy of Medicine (formerly the Institute of Medicine) made the following provisional recommendation for cumulative gestational weight gain by term for patients carrying twins [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Body mass index (BMI) &lt;18.5 kg/m<sup>2</sup> (underweight) – No recommendation due to insufficient data.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>BMI 18.5 to 24.9 kg/m<sup>2</sup> (normal weight) – 37 to 54 lb (16.8 to 24.5 kg).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>BMI 25.0 to 29.9 kg/m<sup>2</sup> (overweight) – 31 to 50 lb (14.1 to 22.7 kg).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>BMI ≥30.0 kg/m<sup>2</sup> (obese) – 25 to 42 lb (11.4 to 19.1 kg). </p><p></p><p class="bulletIndent1">The National Academy of Medicine did not make separate recommendations for different classes of obesity, but another group used data from the US National Center for Health Statistics to suggest optimal cumulative weight gains of 22 to 44 lbs (10.0 to 19.9 kg) for class 1 obesity, 16 to 38 lbs (7.5 to 17.4 kg) for class 2 obesity, and 11 to 22 lbs ( 5.0 to 9.9 kg) for class 3 obesity [<a href="#rid3">3</a>]. The study population included over 260,000 pregnant people between 18 and 45 years of age who gave birth at 24 and 42 weeks of gestation to live-born twins without congenital anomalies from 2014 to 2018. Optimal cumulative weight gain was defined as the threshold below or above which the risk for an adverse perinatal outcome increased.</p><p></p><p>These thresholds represent the 25<sup>th</sup> through 75<sup>th</sup> percentile weight gains in patients who gave birth to twins weighing at least 2500 g [<a href="#rid4">4</a>]. Patients who met these guidelines generally had fewer preterm births and higher birth weights compared with those who did not meet the minimum weight gain suggested by the guidelines, while exceeding the guideline generally increased maternal risks of gestational hypertension/preeclampsia, eclampsia, and cesarean birth [<a href="#rid5">5,6</a>]. Poor gestational weight gain after 20 weeks appears to have a greater impact than poor first-trimester weight gain [<a href="#rid7">7</a>]; thus, we reassure patients in early pregnancy who are unable to achieve caloric intake or weight gain targets due to nausea and vomiting or other reasons.</p><p>To achieve appropriate gestational weight gain, a patient beginning pregnancy with a BMI in the underweight or normal range needs to increase their dietary intake by approximately 300 kcal/day above that for a singleton pregnancy or 600 kcal/day above that for a nonpregnant female. After 20 weeks of gestation, weight gain should be approximately 1.75 pounds (0.8 kg)/week for underweight pregnant persons and approximately 1.5 pounds (0.7 kg)/week for normal weight pregnant persons, with slightly lower weekly weight gain in pregnant persons who are overweight or obese. </p><p class="headingAnchor" id="H1318765406"><span class="h2">Nutrition and supplements</span><span class="headingEndMark"> — </span>We follow Society for Maternal-Fetal Medicine twin pregnancy caloric requirement and supplement recommendations, as shown in the table  (<a class="graphic graphic_table graphicRef113748" href="/z/d/graphic/113748.html" rel="external">table 1</a>) [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H910202395"><span class="h2">Physical and sexual activity, exercise</span><span class="headingEndMark"> — </span>In early pregnancy, patients with uncomplicated twin pregnancies can usually follow the same exercise/physical activity recommendations as those with singleton pregnancies as a definitive association between preterm birth and exercise or physical activity in twin pregnancies has not been established. We do assess for individual risk factors for preterm birth and counsel the patient accordingly. </p><p>As pregnancy progresses, physical changes generally limit the duration and type of exercise performed. Although case reports describe elite athletes who trained until giving birth despite a twin pregnancy, some restriction of activity is generally desired and prudent. Recommendations for individual patients depend on factors such as overall state of health and fitness, proposed exercise regimen, and musculoskeletal factors. (See  <a class="medical medical_review" href="/z/d/html/412.html" rel="external">"Exercise during pregnancy and the postpartum period"</a>.)Patients often inquire about work and sexual activity during pregnancy. Guidance is the same as that for patients with singleton pregnancies, with no restrictions for uncomplicated pregnancies. However, patients should be aware that working &gt;28 hours/week and irregular working times (eg, working in the evening and/or at night) at 16 to 20 weeks of gestation increased the risk of preterm birth &lt;32 weeks in a prospective observational study [<a href="#rid9">9</a>]. Little or no freedom in performing tasks and high physical workload were additional risk factors for very preterm birth in patients working &gt;28 hours/week. For patients with complications such as vaginal bleeding, short or dilated cervix, placenta previa, preterm labor, or vasa previa, restrictions on activity are prudent and reasonable. </p><p class="headingAnchor" id="H1660894012"><span class="h1">PREECLAMPSIA PREVENTION</span><span class="headingEndMark"> — </span>Twin pregnancy is an indication for low-dose <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> preeclampsia prophylaxis, since patients with twins are at increased risk for developing preeclampsia. The dose is the same as that in singleton pregnancies. Dosing and evidence of efficacy are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Low-dose aspirin'</a>.)</p><p class="headingAnchor" id="H1301339875"><span class="h1">SCREENING</span><span class="headingEndMark"> — </span>Patients with twin pregnancies are offered the same screening tests as those with singleton pregnancies, with some differences, which are discussed below. (See  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a> and  <a class="medical medical_review" href="/z/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a>.)</p><p class="headingAnchor" id="H3085090618"><span class="h2">Screening for Down syndrome (trisomy 21)</span></p><p class="headingAnchor" id="H1463537648"><span class="h3">Risk based on maternal age and zygosity</span></p><p class="bulletIndent1"><span class="glyph">●</span>For dizygotic twin pregnancies, the risk of at least one affected fetus is assumed to be twice the risk of a maternal age-matched singleton pregnancy (eg, at age 35: 2 x 1/350 at delivery) and the risk of two affected fetuses is assumed to be the product of the risk of the maternal age-matched singleton pregnancy (eg, at age 35: 1/350 x 1/350 at delivery).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A monozygotic twin pregnancy is thought to have the same Down syndrome risk as a maternal age-matched singleton pregnancy  (<a class="graphic graphic_table graphicRef75423" href="/z/d/graphic/75423.html" rel="external">table 2</a>); both fetuses will be affected or both fetuses will be unaffected. Rarely, however, the twins have different genotypes due to postzygotic events, including nondisjunction and mosaicism [<a href="#rid10">10-15</a>]. They can also be discordant for X-inactivation (in females), differential gene imprinting, and smaller scale genetic abnormalities, such as microdeletions [<a href="#rid16">16</a>].</p><p></p><p>However, at least one study reported that the observed incidence of Down syndrome in twin pregnancies is less than expected, possibly due to an increased frequency of early fetal loss [<a href="#rid17">17</a>]. In this study, the observed incidence of Down syndrome in dizygotic twin pregnancies was 75 percent of the expected incidence; in monozygotic twins, the observed incidence was 34 percent of expected. More data are needed before adjusting Down syndrome risk estimates.</p><p>Sesquizygotic twins are an extremely rare intermediate between monozygotic and dizygotic twinning. (See  <a class="medical medical_review" href="/z/d/html/6821.html" rel="external">"Twin pregnancy: Overview", section on 'Relationship between chorionicity, amnionicity, and zygosity'</a>.)</p><p class="headingAnchor" id="H260966586"><span class="h3">Test options</span><span class="headingEndMark"> — </span>For patients who choose to undergo screening for Down syndrome, we suggest either the first-trimester combined test or cell-free DNA. While the combined test provides early, fetus-specific risk assessment, cell-free DNA has higher detection rates. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Noninvasive screening using cell-free DNA</strong> – Noninvasive prenatal screening for Down syndrome using cell-free DNA is more complicated than in singletons because the average fetal fraction for each twin is less than that for singletons (although the total fetal fraction is higher in twin pregnancies) and the fetal fraction can differ between twins by at least 1.5-fold in 10 percent of cases [<a href="#rid18">18</a>]. Cell-free DNA findings may also be affected by early loss of one or more embryos of a multiple gestation. </p><p></p><p class="bulletIndent1">Testing is commercially available for trisomies 21, 18, and 13. Although less validation data are available from twin gestations than from singletons [<a href="#rid19">19-22</a>], increasing evidence suggests that the sensitivity of the cell-free DNA test for Down syndrome in twins is similar to that in singleton pregnancies [<a href="#rid23">23-26</a>]. In a multicenter study that evaluated cell-free DNA results for trisomy 21 in 1447 twin pregnancies, trisomy 21 was detected in 41 of 42 pregnancies (97.6 percent sensitivity), with no false-positive cases; trisomy 18 was detected in all 10 affected pregnancies (100 percent sensitivity), with one false-positive case; and trisomy 13 was detected in four of five cases (80 percent sensitivity), with no false-positive cases [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">Studies also generally report a higher rate of test failure in twins [<a href="#rid23">23-25</a>], but exceptions exist [<a href="#rid26">26</a>]. In the multicenter study described above, the nonreportable rate was 3.9 percent [<a href="#rid27">27</a>]. When a cell-free DNA test failure occurs, ultrasound and diagnostic testing should be offered but if time is sufficient, a second sample draw may also be considered [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1">The American College of Obstetricians and Gynecologists (ACOG) and The International Society for Prenatal Diagnosis (ISPD) provide the following guidance:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2020 ACOG practice bulletin states that cell-free DNA screening for Down syndrome can be done in twin pregnancies, and available performance data are encouraging, but the total number of reported affected pregnancies is small, thus preventing an accurate assessment of performance [<a href="#rid28">28</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2021 ISPD position statement on cell-free DNA screening for Down syndrome in multiple gestations concluded that cell-free DNA screening for common trisomies in twins provides higher positive predictive values compared with serum- and nuchal translucency-based screening tests [<a href="#rid18">18</a>]. Test failures occur in a median 3.6 percent of cases (range 1.6 to 13.2 percent), which is higher than the rate in singletons and usually due to a low fetal fraction. (See  <a class="medical medical_review" href="/z/d/html/458.html" rel="external">"Prenatal screening for common aneuploidies using cell-free DNA", section on 'Twins'</a>.)</p><p></p><p class="bulletIndent1">Patients who screen-positive (ie, high risk) should be offered chorionic villus sampling (CVS) or amniocentesis for diagnostic genetic testing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>First-trimester combined test</strong> – Increased nuchal translucency (NT) is a marker for Down syndrome, other aneuploidies, congenital malformations, and development of twin-twin transfusion syndrome (TTTS). The first-trimester combined test, which consists of ultrasound measurement of NT plus serum markers (beta human chorionic gonadotropin [beta-hCG] and pregnancy-associated plasma protein A [PAPP-A]) can provide fetus-specific risk assessment for Down syndrome in twin pregnancies. (See  <a class="medical medical_review" href="/z/d/html/422.html" rel="external">"First-trimester combined test and integrated tests for screening for Down syndrome and trisomy 18", section on 'Combined test'</a>.)</p><p></p><p class="bulletIndent1">Interpretation of maternal serum markers alone is problematic in twin pregnancies since both twins contribute to the concentration of the markers and marker levels may be affected by early loss of one or more embryos of a multiple gestation [<a href="#rid29">29,30</a>]. NT measurement can improve the detection rate and, importantly, help to identify which fetus is affected [<a href="#rid31">31,32</a>]. In a systematic review of first-trimester combined risk assessment (NT and maternal serum markers) in twin pregnancies, test sensitivity in dichorionic twins was 86 percent (95% CI 73-94) and test sensitivity in monochorionic twins was 87 percent (95% CI 53-98) [<a href="#rid33">33</a>]. At our institution, first-trimester combined risk assessment identified all six affected pregnancies (five discordant and one concordant for Down syndrome) at a screen-positive rate of 5 percent, while NT alone detected five of six affected fetuses [<a href="#rid32">32</a>]. Although serum marker testing enhanced risk assessment, the levels in affected twin pregnancies were closer to the median levels than in affected singleton pregnancies.</p><p></p><p class="bulletIndent1">Of note, the false-positive rate of NT screening is higher in monochorionic than dichorionic twins because increased NT can be an early manifestation of twin-twin transfusion syndrome as well as a marker of aneuploidy [<a href="#rid34">34</a>]. Also, in vitro fertilization (IVF) affects serum marker levels used in Down syndrome screening and may be considered by some laboratories when calculating screening results in twins conceived by this method [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/z/d/html/414.html" rel="external">"Maternal serum marker screening for Down syndrome: Levels and laboratory issues", section on 'IVF and other infertility treatments'</a>.)</p><p></p><p class="bulletIndent1">Also of note, fetuses with the same genotype may have different phenotypes; as an example, only one fetus of twins with Down syndrome may have increased NT. In a series of eight monochorionic twin pairs discordant for NT who were karyotyped, discordance was a marker for concordant chromosome abnormalities in one twin pair and discordant chromosomal abnormalities in two twin pairs [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1">Patients who screen-positive (ie, high risk) should be offered amniocentesis for diagnostic genetic testing. A second screening with a cell-free DNA test is another option because of its higher sensitivity and lower false-positive rate, but the challenge of screening both fetuses from one maternal sample and the limitations of screening (&lt;100 percent sensitivity and specificity) remain.</p><p></p><p class="headingAnchor" id="H2147923939"><span class="h3">Diagnostic testing</span><span class="headingEndMark"> — </span>Both fetuses should be karyotyped when karyotyping is performed since even monozygotic twins may be discordant. Issues related to diagnostic genetic testing in twins by CVS and genetic amniocentesis are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/449.html" rel="external">"Chorionic villus sampling", section on 'Multiple gestations'</a> and  <a class="medical medical_review" href="/z/d/html/5390.html" rel="external">"Diagnostic amniocentesis", section on 'Multiple gestation'</a>.)</p><p class="headingAnchor" id="H4167171995"><span class="h2">Screening for congenital anomalies</span><span class="headingEndMark"> — </span>An anatomic survey is typically performed at 18 to 20 (or 22) weeks of gestation in all twin pregnancies [<a href="#rid36">36</a>], as well as all singleton pregnancies [<a href="#rid37">37</a>]. The incidence of congenital anomalies is three- to fivefold higher in monozygotic twins than in dizygotic twins or singletons and is higher in monozygotic monochorionic twins than in monozygotic dichorionic twins [<a href="#rid38">38-42</a>]. In one study, the frequency of congenital anomalies in monochorionic twins was 634/10,000 versus 344/10,000 for dichorionic twins versus 238/10,000 for singletons [<a href="#rid41">41</a>].</p><p>The concordance rates for any congenital malformation in monozygotic and dizygotic twin pairs was 37 and 17 percent, respectively, in a study of nearly 3400 twin pairs [<a href="#rid43">43</a>]. Cases of pregnancy termination before 20 weeks of gestation, fetal chromosomal abnormalities, fetal abnormalities related to twin-unique complications (eg, twin–twin transfusion syndrome, twin reversed arterial perfusion sequence) were excluded. </p><p>Twins are not predisposed to any specific type of congenital anomaly, although congenital heart disease is more prevalent in monochorionic twins, particularly those with TTTS [<a href="#rid40">40</a>]. In addition to an anatomic survey at 18 to 20 weeks of gestation, we perform fetal echocardiography at 18 to 20 weeks for monochorionic but not dichorionic twins because 2 to 10 percent of monochorionic twins referred for routine fetal echocardiography have congenital heart disease in at least one twin [<a href="#rid44">44,45</a>] and fetal echocardiography has a role in the diagnosis and management of TTTS. Although some studies have reported an increased risk of congenital heart disease in twins conceived by assisted reproductive technology, particularly IVF, compared with spontaneously conceived twins [<a href="#rid46">46,47</a>], others do not support this association [<a href="#rid48">48-51</a>]. We generally do not refer twin pregnancies for fetal echocardiography for the sole indication of conception via IVF, but some authorities consider IVF an indication for echocardiography in all twin pregnancies [<a href="#rid52">52</a>].</p><p>The reported accuracy of ultrasound for detection of fetal anomalies in twins varies because of differences in ascertainment postnatally and at pregnancy termination, criteria for defining an anomaly, and operator capability. Ultrasound examination can detect the majority of major malformations in twins when performed by sonographers experienced in both anomaly detection and assessment of multiple gestation. Sometimes more than one examination needs to be performed to adequately assess both twins.</p><p class="headingAnchor" id="H2533065656"><span class="h2">Screening for short cervical length</span><span class="headingEndMark"> — </span>At the second trimester fetal anatomy scan, we routinely evaluate cervical length by transabdominal ultrasound and then perform transvaginal ultrasound if the cervix is not well imaged or if it appears short. Others [<a href="#rid53">53</a>], including some UpToDate authors and editors, have taken a different approach: they measure cervical length by transvaginal ultrasound every two weeks between 16 and 24 weeks, as in singleton pregnancies. Practice patterns regarding cervical length measurement in twin pregnancies vary among clinicians (even among those working in the same medical facility), given the lack of high quality evidence favoring one approach over another [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/450.html" rel="external">"Short cervix before 24 weeks: Screening and management in singleton pregnancies"</a>.)</p><p>For patients with a short cervix, options include placement of a cerclage or treatment with daily vaginal <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">progesterone</a>. Management is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/131147.html" rel="external">"Twin pregnancy: Management of pregnancy complications", section on 'Preterm labor and birth'</a>.) </p><p class="headingAnchor" id="H3599896682"><span class="h2">Screening for fetal growth restriction and discordance</span><span class="headingEndMark"> — </span>Evaluation of fetal growth is particularly important in twin gestations because growth restriction and preterm birth are major causes of the higher morbidity/mortality rates in twin compared with singleton gestations [<a href="#rid54">54-63</a>]. However, as in singleton pregnancy, the performance of ultrasound examination for distinguishing the growth restricted fetus from the constitutionally small fetus is limited. (See  <a class="medical medical_review" href="/z/d/html/6752.html" rel="external">"Fetal growth restriction: Screening and diagnosis"</a>.)</p><p class="headingAnchor" id="H1220471294"><span class="h3">Normal growth</span><span class="headingEndMark"> — </span>In the first and second trimesters, the growth rate of twins is not significantly different from that of singletons [<a href="#rid64">64</a>]. In the third trimester, particularly after 30 to 32 weeks of gestation, most studies have described slower fetal growth in uncomplicated twin gestations than in uncomplicated singleton gestations [<a href="#rid64">64,65</a>]. A prospective cohort study reported that almost 40 percent of dichorionic twins near term would be classified as small for gestational age if a singleton growth standard was used [<a href="#rid65">65</a>]. The slower growth rate has been attributed to anomalous umbilical cord insertion and to placental crowding (poor early development due to placental proximity).</p><p>Growth curves have been derived specifically for twins but are of limited usefulness since they were derived from relatively small populations and generally did not consider chorionicity and amnionicity or outcome. We and others believe that singleton growth curves are the best predictor of adverse pregnancy and developmental outcome in twin gestations and should be used for evaluating twins for growth abnormalities [<a href="#rid66">66</a>]. On the other hand, proponents of using twin growth curves state that singleton growth curves overdiagnose growth abnormalities, which can lead to unnecessary maternal anxiety, extra antenatal testing, and possibly iatrogenic preterm birth without improving neonatal outcome [<a href="#rid67">67,68</a>].</p><p class="headingAnchor" id="H3034604258"><span class="h3">Approach to monitoring fetal growth</span><span class="headingEndMark"> — </span>Serial ultrasound examinations are performed in the second and third trimesters to screen for growth restriction and growth discordance, given the risk of adverse outcome associated with these conditions and the insensitivity of symphysis-fundal height measurement for identifying fetal growth abnormalities in twins [<a href="#rid69">69-71</a>]. Although growth monitoring is typically performed in the second and third trimesters, discordance in crown-rump length may be observed as early as the first trimester and is predictive of later weight discordance. (See  <a class="medical medical_review" href="/z/d/html/410.html" rel="external">"Diagnosis and outcome of first-trimester growth delay", section on 'Twin pregnancies'</a>.)</p><p>The growth of dichorionic twins who are both appropriate for gestational age is assessed every four to six weeks. In monochorionic twins, ultrasound examination is typically performed more frequently because they are also being monitored for development of TTTS, TAPS, and sFGR. (See  <a class="medical medical_review" href="/z/d/html/6789.html" rel="external">"Twin-twin transfusion syndrome: Screening, prevalence, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/120803.html" rel="external">"Selective fetal growth restriction in monochorionic twin pregnancies"</a>.)</p><p class="headingAnchor" id="H2476858514"><span class="h4">Diagnosis of growth discordance and restriction</span><span class="headingEndMark"> — </span>Estimated fetal weight and/or abdominal circumference can be used to monitor growth. (See  <a class="medical medical_review" href="/z/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight", section on 'Sonographic assessment of fetal weight'</a>.) Growth abnormalities manifest in three ways:</p><p class="bulletIndent1"><span class="glyph">●</span>One twin can be small for gestational age (called selective fetal growth restriction)</p><p class="bulletIndent1"><span class="glyph">●</span>Both twins can be small for gestational age, or </p><p class="bulletIndent1"><span class="glyph">●</span>One twin can be significantly smaller than the other twin (ie, growth discordance) although neither is small for gestational age. In almost two-thirds of discordant twin pairs, the smaller twin has a birth weight &lt;10th percentile [<a href="#rid57">57</a>].</p><p></p><p>There is no consensus regarding the optimum threshold for defining growth discordance in twins. Discordance in birth weight ranging from 15 to 40 percent has been considered predictive of adverse outcome [<a href="#rid56">56,58-60,72-76</a>]. We use an estimated weight difference ≥20 percent as the threshold for defining discordance, but ≥25 percent is also commonly used; both have low sensitivity (approximately 50 percent) but good specificity (approximately 90 percent) for predicting weight discordance at birth [<a href="#rid77">77</a>]. An intertwin abdominal circumference difference ≥20 mm, irrespective of gestational age is another threshold for defining growth discordance and has been reported to have 83 percent positive predictive value to detect a difference in birth weight ≥20 percent [<a href="#rid78">78</a>]. Discordance in other biometric measurements subsequently associated with adverse obstetric and neonatal outcome has also been described [<a href="#rid79">79,80</a>].</p><p>Despite routine use of ultrasound to monitor fetal growth, its ability to accurately identify discordant twins and adverse perinatal outcome is limited. In a systematic review, estimated fetal weight discordance ≥20 percent had sensitivity and specificity of 65 and 91 percent, respectively, for predicting birth weight discordance ≥20 percent [<a href="#rid81">81</a>].</p><p>There is no convincing evidence that Doppler velocimetry has benefits for detecting growth restriction over the use of ultrasound alone; therefore, routine use of Doppler velocimetry in twin gestations is not recommended [<a href="#rid82">82,83</a>]. However, Doppler ultrasound is useful for monitoring pregnancies in which the diagnosis of growth restriction, discordance, or fetal anemia has been made. (See  <a class="medical medical_review" href="/z/d/html/120803.html" rel="external">"Selective fetal growth restriction in monochorionic twin pregnancies", section on 'Classification-based approach'</a>.)</p><p>The management of growth restriction and/or discordance depends on chorionicity. (See  <a class="medical medical_review" href="/z/d/html/131147.html" rel="external">"Twin pregnancy: Management of pregnancy complications", section on 'Growth restriction and discordance'</a>.)</p><p class="headingAnchor" id="H1050885061"><span class="h2">Screening for placental abnormalities</span><span class="headingEndMark"> — </span>Sonographic evaluation of the placenta is particularly important in twin pregnancies because they are at increased risk of placental findings associated with adverse outcome. Identification and appropriate management of affected pregnancies can improve pregnancy outcome. These findings include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placenta previa</strong> – The incidence of placenta previa in twin pregnancy is higher than in singletons (3.9 per 1000 live births versus 2.8 per 1000 live births) [<a href="#rid84">84</a>]. This has been attributed to the larger total area of twin placentas, especially dichorionic twin placentas. (See  <a class="medical medical_review" href="/z/d/html/6772.html" rel="external">"Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality"</a> and  <a class="medical medical_review" href="/z/d/html/6809.html" rel="external">"Placenta previa: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vasa previa</strong> – The incidence of vasa previa in twin pregnancies is higher than in the general obstetric population (0.43 versus 0.04 percent [<a href="#rid85">85</a>]), consistent with the increased risk for placenta previa in twins [<a href="#rid86">86,87</a>]. Transvaginal examination with color Doppler mapping will detect vasa previa. (See  <a class="medical medical_review" href="/z/d/html/6807.html" rel="external">"Velamentous umbilical cord insertion and vasa previa"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Velamentous cord insertion</strong> – Velamentous cord insertion, which is associated with an increased risk for fetal growth restriction and cord compression, has been reported in 12 percent of monochorionic twin pregnancies, 7 percent of dichorionic twin pregnancies, and 2 percent of singleton pregnancies [<a href="#rid88">88</a>]. (See  <a class="medical medical_review" href="/z/d/html/6807.html" rel="external">"Velamentous umbilical cord insertion and vasa previa"</a>.)</p><p></p><p class="headingAnchor" id="H1573469177"><span class="h1">PREGNANCY MONITORING BASED ON CHORIONICITY AND AMNIONICITY</span><span class="headingEndMark"> — </span>Because monochorionic twin gestations are associated with greater and different risks than dichorionic twin gestations  (<a class="graphic graphic_table graphicRef66305" href="/z/d/graphic/66305.html" rel="external">table 3</a>), protocols for monitoring monochorionic twins have involved more intensive surveillance than protocols for monitoring dichorionic twins, as described below. </p><p class="headingAnchor" id="H1850059958"><span class="h2">Monochorionic/diamniotic twins</span><span class="headingEndMark"> — </span>Monochorionic/diamniotic twins are at risk for developing TTTS, TAPS, and/or selective fetal growth restriction (sFGR). Early detection can improve perinatal outcome [<a href="#rid89">89,90</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of TTTS is based on the sonographic finding of oligohydramnios (maximal vertical pocket &lt;2 cm) and polyhydramnios (maximal vertical pocket &gt;8 cm). A specific protocol for monitoring  (<a class="graphic graphic_table graphicRef118804" href="/z/d/graphic/118804.html" rel="external">table 4</a>) and management of affected pregnancies are described separately. (See  <a class="medical medical_review" href="/z/d/html/6789.html" rel="external">"Twin-twin transfusion syndrome: Screening, prevalence, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6793.html" rel="external">"Twin-twin transfusion syndrome: Management and outcome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of TAPS is based on MCA-PSV &gt;1.5 multiples of the median (MoM) in one twin and &lt;0.8 MoM in the other twin. A specific protocol for monitoring  (<a class="graphic graphic_table graphicRef118804" href="/z/d/graphic/118804.html" rel="external">table 4</a>) and management of affected pregnancies are described separately. (See  <a class="medical medical_review" href="/z/d/html/130852.html" rel="external">"Twin anemia-polycythemia sequence (TAPS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of sFGR in the second trimester is based on:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Estimated fetal weight (EFW)<sup> </sup>&lt;3<sup>rd</sup> percentile of one fetus <strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>At least two of the four following criteria:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>EFW &lt;10<sup>th</sup> percentile for one twin</p><p class="bulletIndent3"><span class="glyph">-</span>Abdominal circumference &lt;10<sup>th</sup> percentile for one twin</p><p class="bulletIndent3"><span class="glyph">-</span>Weight discordance ≥25 percent</p><p class="bulletIndent3"><span class="glyph">-</span>UA pulsatility index &gt;95<sup>th</sup> percentile for the smaller twin </p><p></p><p class="bulletIndent1">Monochorionic placentation is a significant risk factor for discordant growth due to unequal sharing of the placenta or TTTS [<a href="#rid91">91-95</a>], although monochorionic placentation also appears to have a small independent adverse effect on intrauterine growth [<a href="#rid96">96</a>]. sFGR is different from the deficient uteroplacental perfusion that occurs in dichorionic twins and singletons. A specific protocol for monitoring  (<a class="graphic graphic_table graphicRef118804" href="/z/d/graphic/118804.html" rel="external">table 4</a>) and management of affected pregnancies are described separately. (See  <a class="medical medical_review" href="/z/d/html/120803.html" rel="external">"Selective fetal growth restriction in monochorionic twin pregnancies"</a>.)</p><p></p><p class="headingAnchor" id="H3388271588"><span class="h2">Monochorionic/monoamniotic twins</span><span class="headingEndMark"> — </span>Monochorionic/monoamniotic twins are at highest risk of adverse outcome because of the risk of cord entanglement; rarely, monoamniotic twins are conjoined. Monitoring and management of these pregnancies is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/6766.html" rel="external">"Monoamniotic twin pregnancy (including conjoined twins)"</a>.)</p><p class="headingAnchor" id="H2877646195"><span class="h2">Dichorionic twins</span><span class="headingEndMark"> — </span>Dichorionic twins are at risk for growth restriction, but they are not at risk for TTTS and TAPS. A common practice is to perform an ultrasound examination every four to six weeks after 20 weeks of gestation to monitor fetal growth, as fetal growth deceleration leading to discordancy is optimally detected between 20 and 28 weeks of gestation [<a href="#rid92">92</a>]. Many twin fetuses with growth abnormalities can be identified by 20 to 24 weeks, so if there is no evidence of growth abnormality at that time, then repeated scanning might not be necessary [<a href="#rid97">97</a>]; however, we continue serial ultrasound assessment until birth. Routinely scanning every two to four weeks has been recommended by some authorities [<a href="#rid53">53</a>] and detected more abnormalities that prompted early delivery in one study, but whether this resulted in better perinatal outcomes was not determined [<a href="#rid98">98</a>].</p><p class="headingAnchor" id="H1933471667"><span class="h1">ANTEPARTUM FETAL TESTING</span><span class="headingEndMark"> — </span>Routine use of antepartum fetal testing (nonstress test [NST], biophysical profile [BPP], amniotic fluid volume determination, or Doppler velocimetry) has no proven benefit in uncomplicated twin pregnancies. However, antepartum fetal monitoring in twins is widely practiced beginning at approximately 32 weeks of gestation because of the increased risk of stillbirth in twins, particularly monochorionic twins [<a href="#rid99">99</a>]. The exact timing of initiation of testing varies among centers, depending on factors such as chorionicity and amnionicity and underlying complications. </p><p>In our practice, we routinely perform weekly testing in dichorionic twins beginning at 32 to 36 weeks, and in monochorionic diamniotic twin pregnancies beginning at 28 to 32 weeks of gestation; monochorionic monoamniotic twins are followed more closely (see  <a class="medical medical_review" href="/z/d/html/6766.html" rel="external">"Monoamniotic twin pregnancy (including conjoined twins)"</a>). If complications such as growth restriction develop, then testing is initiated earlier and/or performed more frequently. Either NSTs or BPPs can be used [<a href="#rid100">100-102</a>]. The best technique to assess amniotic fluid volume in diamniotic twin gestations is uncertain. Subjective assessment of the volume of amniotic fluid in each sac appears to be as accurate as quantitative assessment; however, the maximal vertical pocket (single deepest pocket) in each sac is commonly used. Using the amniotic fluid index (AFI), a four-quadrant technique used in singletons, is not appropriate in twin pregnancy. (See  <a class="medical medical_review" href="/z/d/html/462.html" rel="external">"Assessment of amniotic fluid volume", section on 'Multifetal pregnancy'</a>.)</p><p>The American College of Obstetricians and Gynecologists suggests considering weekly antenatal fetal surveillance at 36+0 weeks of gestation for uncomplicated dichorionic twins, and individualizing surveillance of complicated dichorionic twin pregnancies [<a href="#rid103">103</a>]. For monochorionic twins, antenatal fetal surveillance is typically initiated at 32+0 weeks of gestation because of the increased risk of fetal death in these pregnancies. </p><p class="headingAnchor" id="H4025960849"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/123102.html" rel="external">"Society guideline links: Multiple gestation"</a>.)</p><p class="headingAnchor" id="H2243286580"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/85877.html" rel="external">"Patient education: Having twins (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3839176295"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Weight gain and nutrition</strong>: We follow National Academy of Medicine (formerly the Institute of Medicine) guidelines for cumulative weight gain by term for patients carrying twins (see <a class="local">'Gestational weight gain'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>BMI 18.5 to 24.9 kg/m<sup>2</sup> (normal weight) – Weight gain 37 to 54 lb (16.8 to 24.5 kg).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>BMI 25.0 to 29.9 kg/m<sup>2</sup> (overweight) – Weight gain 31 to 50 lb (14.1 to 22.7 kg).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>BMI ≥30.0 kg/m<sup>2</sup> (obese) – Weight gain 25 to 42 lb (11.4 to 19.1 kg).</p><p></p><p class="bulletIndent1">We also follow Society for Maternal-Fetal Medicine twin pregnancy caloric requirement and supplement recommendations, as shown in the table  (<a class="graphic graphic_table graphicRef113748" href="/z/d/graphic/113748.html" rel="external">table 1</a>). (See <a class="local">'Nutrition and supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preeclampsia prophylaxis: </strong>We suggest low-dose <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> prophylaxis to reduce the risk of developing preeclampsia (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). Patients with twin pregnancies are a high-risk group for developing preeclampsia. (See  <a class="medical medical_review" href="/z/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Low-dose aspirin'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical activity: </strong>In early pregnancy, patients with uncomplicated twin pregnancies can generally follow the same exercise/physical activity recommendations as those with singleton pregnancies; however, the clinician should assess individual risk factors for preterm birth and counsel the patient accordingly. As pregnancy progresses, physical changes generally limit the duration and type of exercise performed. (See <a class="local">'Physical and sexual activity, exercise'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Down syndrome screening: </strong>For women who choose to undergo screening for Down syndrome, we suggest either first-trimester combined test or noninvasive screening using cell-free DNA in maternal blood. While the combined test provides early, fetus-specific risk assessment because of inclusion of nuchal translucency measurement, cell-free fetal DNA has higher detection rates. Both fetuses should be karyotyped when karyotyping is performed since even monozygotic twins may be discordant. (See <a class="local">'Screening for Down syndrome (trisomy 21)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening for short cervical length:</strong> At the fetal anatomy scan at 18 to 22 weeks of gestation, we routinely evaluate cervical length by transabdominal ultrasound and then perform transvaginal ultrasound if the cervix is not well imaged or if it appears short. Others, including some UpToDate authors and editors, measure cervical length by transvaginal ultrasound every two weeks between 16 and 24 weeks, as in singleton pregnancies at high risk for preterm birth. Practice patterns regarding cervical length measurement in twin pregnancies vary among clinicians (even among those working in the same medical facility), given the lack of high quality evidence favoring one approach over another. (See <a class="local">'Screening for short cervical length'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening for congenital anomalies: </strong>Each twin of a dizygotic pair has a similar congenital anomaly rate as a singleton and anomalies, if present, have a low concordance rate. The concordance rate of major congenital malformations in monozygotic twins is approximately 20 percent. In addition to a sonographic anatomic survey, we perform fetal echocardiography at 18 to 20 weeks for monochorionic but not dichorionic twins because 2 to 10 percent of monochorionic twins referred for routine fetal echocardiography have congenital heart disease in at least one twin and fetal echocardiography has a role in the diagnosis and management of twin-twin transfusion syndrome. (See <a class="local">'Screening for congenital anomalies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring fetal growth: </strong>Growth restriction is more common in twin than in singleton pregnancies and can manifest in three ways (see <a class="local">'Screening for fetal growth restriction and discordance'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One twin can be small for gestational age (called selective fetal growth restriction)</p><p class="bulletIndent2"><span class="glyph">•</span>Both twins can be small for gestational age, or</p><p class="bulletIndent2"><span class="glyph">•</span>One twin can be significantly smaller than the other twin (ie, growth discordance) although neither is small for gestational age. In almost two-thirds of discordant twin pairs, the smaller twin has a birth weight &lt;10th percentile.</p><p></p><p class="bulletIndent1">The growth of dichorionic twins who are both appropriate for gestational age is assessed every four to six weeks after 20 weeks of gestation. (See <a class="local">'Dichorionic twins'</a> above.)</p><p></p><p class="bulletIndent1">Ultrasound examination is typically performed more frequently than monthly in monochorionic twins because they are also being monitored for development of twin-twin transfusion syndrome (TTTS), twin anemia-polycythemia sequence (TAPS), and selective fetal growth restriction (sFGR). (See <a class="local">'Monochorionic/diamniotic twins'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antepartum fetal testing: </strong>We perform weekly testing with nonstress tests and amniotic fluid evaluation or biophysical profile scoring starting at 32 weeks in almost all twin pregnancies (excluding monochorionic monoamniotic twins). Testing is performed earlier and/or more frequently if complications, such as fetal growth restriction, develop. (See <a class="local">'Antepartum fetal testing'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Dodd JM, Crowther CA. Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes. Cochrane Database Syst Rev 2012; :CD005300.</a></li><li class="breakAll">http://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2009/Weight-Gain-During-Pregnancy-Reexamining-the-Guidelines/Report%20Brief%20-%20Weight%20Gain%20During%20Pregnancy.pdf (Accessed on September 07, 2018).</li><li><a class="nounderline abstract_t">Lin D, Huang X, Fan D, et al. Association of Optimal Gestational Weight Gain Ranges With Perinatal Outcomes Across Body Mass Index Categories in Twin Pregnancies. JAMA Netw Open 2022; 5:e2222537.</a></li><li class="breakAll">www.iom.edu/CMS/3788/48191/68004/68230.aspx (Accessed on May 29, 2009).</li><li><a class="nounderline abstract_t">Lipworth H, Barrett J, Murphy KE, et al. Gestational weight gain in twin gestations and pregnancy outcomes: a systematic review and meta-analysis. BJOG 2022; 129:868.</a></li><li><a class="nounderline abstract_t">Lin D, Huang Z, Fan D, et al. Association between gestational weight gain and perinatal outcomes among twin gestations based on the 2009 Institute of Medicine (IOM) guidelines: a systematic review. J Matern Fetal Neonatal Med 2022; 35:6527.</a></li><li><a class="nounderline abstract_t">Pettit KE, Lacoursiere DY, Schrimmer DB, et al. The association of inadequate mid-pregnancy weight gain and preterm birth in twin pregnancies. J Perinatol 2015; 35:85.</a></li><li><a class="nounderline abstract_t">Goodnight W, Newman R, Society of Maternal-Fetal Medicine. Optimal nutrition for improved twin pregnancy outcome. Obstet Gynecol 2009; 114:1121.</a></li><li><a class="nounderline abstract_t">van Beukering MDM, van Melick MJGJ, Duijnhoven RG, et al. Working conditions in women with multiple pregnancy-the impact on preterm birth and adherence to guidelines: a prospective cohort study. Am J Obstet Gynecol 2023; 228:734.e1.</a></li><li><a class="nounderline abstract_t">Bermúdez C, Becerra CH, Bornick PW, et al. Placental types and twin-twin transfusion syndrome. Am J Obstet Gynecol 2002; 187:489.</a></li><li><a class="nounderline abstract_t">O'Donnell CP, Pertile MD, Sheffield LJ, Sampson A. Monozygotic twins with discordant karyotypes: a case report. J Pediatr 2004; 145:406.</a></li><li><a class="nounderline abstract_t">Nieuwint A, Van Zalen-Sprock R, Hummel P, et al. 'Identical' twins with discordant karyotypes. Prenat Diagn 1999; 19:72.</a></li><li><a class="nounderline abstract_t">Beattie RB, Manson IW, Whittle MJ. Identical twins with trisomy 21 discordant for exomphalos. Prenat Diagn 1993; 13:1067.</a></li><li><a class="nounderline abstract_t">Rogers JG, Voullaire L, Gold H. Monozygotic twins discordant for trisomy 21. Am J Med Genet 1982; 11:143.</a></li><li><a class="nounderline abstract_t">Edlow AG, Reiss R, Benson CB, et al. Monochorionic diamniotic twin gestations discordant for markedly enlarged nuchal translucency. Prenat Diagn 2011; 31:299.</a></li><li><a class="nounderline abstract_t">Peng R, Zhou Y, Xie HN, et al. MCDA twins with discordant malformations: submicroscopic chromosomal anomalies detected by chromosomal microarray analysis and clinical outcomes. Prenat Diagn 2016; 36:766.</a></li><li><a class="nounderline abstract_t">Sparks TN, Norton ME, Flessel M, et al. Observed Rate of Down Syndrome in Twin Pregnancies. Obstet Gynecol 2016; 128:1127.</a></li><li><a class="nounderline abstract_t">Palomaki GE, Chiu RWK, Pertile MD, et al. International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies. Prenat Diagn 2021; 41:1222.</a></li><li><a class="nounderline abstract_t">Lau TK, Jiang F, Chan MK, et al. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013; 26:434.</a></li><li><a class="nounderline abstract_t">Leung TY, Qu JZ, Liao GJ, et al. Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing. Prenat Diagn 2013; 33:675.</a></li><li><a class="nounderline abstract_t">Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012; 32:730.</a></li><li><a class="nounderline abstract_t">Huang X, Zheng J, Chen M, et al. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014; 34:335.</a></li><li><a class="nounderline abstract_t">Gil MM, Galeva S, Jani J, et al. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet Gynecol 2019; 53:734.</a></li><li><a class="nounderline abstract_t">Galeva S, Gil MM, Konstantinidou L, et al. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure. Ultrasound Obstet Gynecol 2019; 53:804.</a></li><li><a class="nounderline abstract_t">van Riel M, Brison N, Baetens M, et al. Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations. Obstet Gynecol 2021; 137:1102.</a></li><li><a class="nounderline abstract_t">Khalil A, Archer R, Hutchinson V, et al. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study. Am J Obstet Gynecol 2021; 225:79.e1.</a></li><li><a class="nounderline abstract_t">Dugoff L, Koelper NC, Chasen ST, et al. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study. Am J Obstet Gynecol 2023; 229:435.e1.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol 2020; 136:e48.</a></li><li><a class="nounderline abstract_t">Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 2010; 30:235.</a></li><li><a class="nounderline abstract_t">Chasen ST, Perni SC, Predanic M, et al. Does a "vanishing twin" affect first-trimester biochemistry in Down syndrome risk assessment? Am J Obstet Gynecol 2006; 195:236.</a></li><li><a class="nounderline abstract_t">Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 2003; 110:276.</a></li><li><a class="nounderline abstract_t">Chasen ST, Perni SC, Kalish RB, Chervenak FA. First-trimester risk assessment for trisomies 21 and 18 in twin pregnancy. Am J Obstet Gynecol 2007; 197:374.e1.</a></li><li><a class="nounderline abstract_t">Prats P, Rodríguez I, Comas C, Puerto B. Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis. Prenat Diagn 2014; 34:1077.</a></li><li><a class="nounderline abstract_t">Stagnati V, Zanardini C, Fichera A, et al. Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2017; 49:573.</a></li><li><a class="nounderline abstract_t">Maymon R, Neeman O, Shulman A, et al. Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble. Prenat Diagn 2005; 25:746.</a></li><li><a class="nounderline abstract_t">Oliver E, Navaratnam K, Gent J, et al. Comparison of international guidelines on the management of twin pregnancy. Eur J Obstet Gynecol Reprod Biol 2023; 285:97.</a></li><li><a class="nounderline abstract_t">Emery SP, Bahtiyar MO, Dashe JS, et al. The North American Fetal Therapy Network Consensus Statement: prenatal management of uncomplicated monochorionic gestations. Obstet Gynecol 2015; 125:1236.</a></li><li><a class="nounderline abstract_t">Cameron AH, Edwards JH, Derom R, et al. The value of twin surveys in the study of malformations. Eur J Obstet Gynecol Reprod Biol 1983; 14:347.</a></li><li><a class="nounderline abstract_t">Sperling L, Kiil C, Larsen LU, et al. Detection of chromosomal abnormalities, congenital abnormalities and transfusion syndrome in twins. Ultrasound Obstet Gynecol 2007; 29:517.</a></li><li><a class="nounderline abstract_t">Bahtiyar MO, Dulay AT, Weeks BP, et al. Prevalence of congenital heart defects in monochorionic/diamniotic twin gestations: a systematic literature review. J Ultrasound Med 2007; 26:1491.</a></li><li><a class="nounderline abstract_t">Glinianaia SV, Rankin J, Wright C. Congenital anomalies in twins: a register-based study. Hum Reprod 2008; 23:1306.</a></li><li><a class="nounderline abstract_t">Weber MA, Sebire NJ. Genetics and developmental pathology of twinning. Semin Fetal Neonatal Med 2010; 15:313.</a></li><li><a class="nounderline abstract_t">Jung YM, Lee SM, Oh S, et al. The concordance rate of non-chromosomal congenital malformations in twins based on zygosity: a retrospective cohort study. BJOG 2021; 128:857.</a></li><li><a class="nounderline abstract_t">Bahtiyar MO, Emery SP, Dashe JS, et al. The North American Fetal Therapy Network consensus statement: prenatal surveillance of uncomplicated monochorionic gestations. Obstet Gynecol 2015; 125:118.</a></li><li><a class="nounderline abstract_t">Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129:2183.</a></li><li><a class="nounderline abstract_t">Tararbit K, Houyel L, Bonnet D, et al. Risk of congenital heart defects associated with assisted reproductive technologies: a population-based evaluation. Eur Heart J 2011; 32:500.</a></li><li><a class="nounderline abstract_t">Panagiotopoulou O, Fouzas S, Sinopidis X, et al. Congenital heart disease in twins: The contribution of type of conception and chorionicity. Int J Cardiol 2016; 218:144.</a></li><li><a class="nounderline abstract_t">Bahtiyar MO, Campbell K, Dulay AT, et al. Is the rate of congenital heart defects detected by fetal echocardiography among pregnancies conceived by in vitro fertilization really increased?: a case-historical control study. J Ultrasound Med 2010; 29:917.</a></li><li><a class="nounderline abstract_t">Iwashima S, Ishikawa T, Itoh H. Reproductive technologies and the risk of congenital heart defects. Hum Fertil (Camb) 2017; 20:14.</a></li><li><a class="nounderline abstract_t">Davies MJ, Moore VM, Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012; 366:1803.</a></li><li><a class="nounderline abstract_t">Schofield SJ, Doughty VL, van Stiphout N, et al. Assisted conception and the risk of CHD: a case-control study. Cardiol Young 2017; 27:473.</a></li><li class="breakAll">AIUM Practice Parameter for the Performance of Fetal Echocardiograph https://www.aium.org/resources/guidelines/fetalecho.pdf (Accessed on July 02, 2018).</li><li><a class="nounderline abstract_t">Khalil A, Rodgers M, Baschat A, et al. ISUOG Practice Guidelines: role of ultrasound in twin pregnancy. Ultrasound Obstet Gynecol 2016; 47:247.</a></li><li><a class="nounderline abstract_t">Adegbite AL, Castille S, Ward S, Bajoria R. Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight. Am J Obstet Gynecol 2004; 190:156.</a></li><li><a class="nounderline abstract_t">Garite TJ, Clark RH, Elliott JP, Thorp JA. Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants. Am J Obstet Gynecol 2004; 191:700.</a></li><li><a class="nounderline abstract_t">Hartley RS, Hitti J, Emanuel I. Size-discordant twin pairs have higher perinatal mortality rates than nondiscordant pairs. Am J Obstet Gynecol 2002; 187:1173.</a></li><li><a class="nounderline abstract_t">Blickstein I, Keith LG. Neonatal mortality rates among growth-discordant twins, classified according to the birth weight of the smaller twin. Am J Obstet Gynecol 2004; 190:170.</a></li><li><a class="nounderline abstract_t">Amaru RC, Bush MC, Berkowitz RL, et al. Is discordant growth in twins an independent risk factor for adverse neonatal outcome? Obstet Gynecol 2004; 103:71.</a></li><li><a class="nounderline abstract_t">Branum AM, Schoendorf KC. The effect of birth weight discordance on twin neonatal mortality. Obstet Gynecol 2003; 101:570.</a></li><li><a class="nounderline abstract_t">Yinon Y, Mazkereth R, Rosentzweig N, et al. Growth restriction as a determinant of outcome in preterm discordant twins. Obstet Gynecol 2005; 105:80.</a></li><li><a class="nounderline abstract_t">Demissie K, Ananth CV, Martin J, et al. Fetal and neonatal mortality among twin gestations in the United States: the role of intrapair birth weight discordance. Obstet Gynecol 2002; 100:474.</a></li><li><a class="nounderline abstract_t">Kingdom JC, Nevo O, Murphy KE. Discordant growth in twins. Prenat Diagn 2005; 25:759.</a></li><li><a class="nounderline abstract_t">Inklaar MJ, van Klink JM, Stolk TT, et al. Cerebral injury in monochorionic twins with selective intrauterine growth restriction: a systematic review. Prenat Diagn 2014; 34:205.</a></li><li><a class="nounderline abstract_t">Alexander GR, Kogan M, Martin J, Papiernik E. What are the fetal growth patterns of singletons, twins, and triplets in the United States? Clin Obstet Gynecol 1998; 41:114.</a></li><li><a class="nounderline abstract_t">Grantz KL, Grewal J, Albert PS, et al. Dichorionic twin trajectories: the NICHD Fetal Growth Studies. Am J Obstet Gynecol 2016; 215:221.e1.</a></li><li><a class="nounderline abstract_t">Gleason JL, Yeung E, Sundaram R, et al. Developmental outcomes in small-for-gestational age twins using a singleton vs twin birthweight reference. Am J Obstet Gynecol MFM 2021; 3:100465.</a></li><li><a class="nounderline abstract_t">Shea SK, Likins BJ, Boan AD, et al. Dichorionic twin-specific vs singleton growth references for diagnosis of fetal growth restriction. Am J Obstet Gynecol 2021; 224:603.e1.</a></li><li><a class="nounderline abstract_t">Hiersch L, Barrett J, Fox NS, et al. Should twin-specific growth charts be used to assess fetal growth in twin pregnancies? Am J Obstet Gynecol 2022; 227:10.</a></li><li><a class="nounderline abstract_t">Lynch L, Lapinski R, Alvarez M, Lockwood CJ. Accuracy of ultrasound estimation of fetal weight in multiple pregnancies. Ultrasound Obstet Gynecol 1995; 6:349.</a></li><li><a class="nounderline abstract_t">Jensen OH, Jenssen H. Prediction of fetal weights in twins. Acta Obstet Gynecol Scand 1995; 74:177.</a></li><li><a class="nounderline abstract_t">Hill LM, Guzick D, Chenevey P, et al. The sonographic assessment of twin growth discordancy. Obstet Gynecol 1994; 84:501.</a></li><li><a class="nounderline abstract_t">Cameron AH. The Birmingham twin survey. Proc R Soc Med 1968; 61:229.</a></li><li><a class="nounderline abstract_t">Breathnach FM, McAuliffe FM, Geary M, et al. Definition of intertwin birth weight discordance. Obstet Gynecol 2011; 118:94.</a></li><li><a class="nounderline abstract_t">D'Antonio F, Khalil A, Dias T, et al. Weight discordance and perinatal mortality in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort. Ultrasound Obstet Gynecol 2013; 41:643.</a></li><li><a class="nounderline abstract_t">Jahanfar S, Lim K, Oviedo-Joekes E. Optimal threshold for birth weight discordance: Does knowledge of chorionicity matter? J Perinatol 2016; 36:704.</a></li><li><a class="nounderline abstract_t">Di Mascio D, Acharya G, Khalil A, et al. Birthweight discordance and neonatal morbidity in twin pregnancies: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2019; 98:1245.</a></li><li><a class="nounderline abstract_t">Jahanfar S, Ho JJ, Jaafar SH, et al. Ultrasound for diagnosis of birth weight discordance in twin pregnancies. Cochrane Database Syst Rev 2021; 3:CD012553.</a></li><li><a class="nounderline abstract_t">Sperling L, Tabor A. Twin pregnancy: the role of ultrasound in management. Acta Obstet Gynecol Scand 2001; 80:287.</a></li><li><a class="nounderline abstract_t">Allaf MB, Campbell WA, Vintzileos AM, et al. Does early second-trimester sonography predict adverse perinatal outcomes in monochorionic diamniotic twin pregnancies? J Ultrasound Med 2014; 33:1573.</a></li><li><a class="nounderline abstract_t">Fox NS, Saltzman DH, Schwartz R, et al. Second-trimester estimated fetal weight and discordance in twin pregnancies: association with fetal growth restriction. J Ultrasound Med 2011; 30:1095.</a></li><li><a class="nounderline abstract_t">Leombroni M, Liberati M, Fanfani F, et al. Diagnostic accuracy of ultrasound in predicting birth-weight discordance in twin pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2017; 50:442.</a></li><li><a class="nounderline abstract_t">Chittacharoen A, Leelapattana P, Rangsiprakarn R. Prediction of discordant twins by real-time ultrasonography combined with umbilical artery velocimetry. Ultrasound Obstet Gynecol 2000; 15:118.</a></li><li><a class="nounderline abstract_t">Giles W, Bisits A, O'Callaghan S, et al. The Doppler assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy. BJOG 2003; 110:593.</a></li><li><a class="nounderline abstract_t">Ananth CV, Demissie K, Smulian JC, Vintzileos AM. Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions. Am J Obstet Gynecol 2003; 188:275.</a></li><li><a class="nounderline abstract_t">Cipriano LE, Barth WH Jr, Zaric GS. The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario. BJOG 2010; 117:1108.</a></li><li><a class="nounderline abstract_t">Jauniaux E, Melcer Y, Maymon R. Prenatal diagnosis and management of vasa previa in twin pregnancies: a case series and systematic review. Am J Obstet Gynecol 2017; 216:568.</a></li><li><a class="nounderline abstract_t">Pavalagantharajah S, Villani LA, D'Souza R. Vasa previa and associated risk factors: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2:100117.</a></li><li><a class="nounderline abstract_t">Kalafat E, Thilaganathan B, Papageorghiou A, et al. Significance of placental cord insertion site in twin pregnancy. Ultrasound Obstet Gynecol 2018; 52:378.</a></li><li><a class="nounderline abstract_t">Sueters M, Middeldorp JM, Lopriore E, et al. Timely diagnosis of twin-to-twin transfusion syndrome in monochorionic twin pregnancies by biweekly sonography combined with patient instruction to report onset of symptoms. Ultrasound Obstet Gynecol 2006; 28:659.</a></li><li><a class="nounderline abstract_t">de Villiers SF, Slaghekke F, Middeldorp JM, et al. Placental characteristics in monochorionic twins with spontaneous versus post-laser twin anemia-polycythemia sequence. Placenta 2013; 34:456.</a></li><li><a class="nounderline abstract_t">Ortibus E, Lopriore E, Deprest J, et al. The pregnancy and long-term neurodevelopmental outcome of monochorionic diamniotic twin gestations: a multicenter prospective cohort study from the first trimester onward. Am J Obstet Gynecol 2009; 200:494.e1.</a></li><li><a class="nounderline abstract_t">González-Quintero VH, Luke B, O'sullivan MJ, et al. Antenatal factors associated with significant birth weight discordancy in twin gestations. Am J Obstet Gynecol 2003; 189:813.</a></li><li><a class="nounderline abstract_t">Fick AL, Feldstein VA, Norton ME, et al. Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins. Am J Obstet Gynecol 2006; 195:178.</a></li><li><a class="nounderline abstract_t">Russell Z, Quintero RA, Kontopoulos EV. Intrauterine growth restriction in monochorionic twins. Semin Fetal Neonatal Med 2007; 12:439.</a></li><li><a class="nounderline abstract_t">Groene SG, Openshaw KM, Jansén-Storbacka LR, et al. Impact of placental sharing and large bidirectional anastomoses on birthweight discordance in monochorionic twins: a retrospective cohort study in 449 cases. Am J Obstet Gynecol 2022; 227:755.e1.</a></li><li><a class="nounderline abstract_t">Papageorghiou AT, Bakoulas V, Sebire NJ, Nicolaides KH. Intrauterine growth in multiple pregnancies in relation to fetal number, chorionicity and gestational age. Ultrasound Obstet Gynecol 2008; 32:890.</a></li><li><a class="nounderline abstract_t">Grobman WA, Parilla BV. Positive predictive value of suspected growth aberration in twin gestations. Am J Obstet Gynecol 1999; 181:1139.</a></li><li><a class="nounderline abstract_t">Corcoran S, Breathnach F, Burke G, et al. Dichorionic twin ultrasound surveillance: sonography every 4 weeks significantly underperforms sonography every 2 weeks: results of the Prospective Multicenter ESPRiT Study. Am J Obstet Gynecol 2015; 213:551.e1.</a></li><li><a class="nounderline abstract_t">Barigye O, Pasquini L, Galea P, et al. High risk of unexpected late fetal death in monochorionic twins despite intensive ultrasound surveillance: a cohort study. PLoS Med 2005; 2:e172.</a></li><li><a class="nounderline abstract_t">Patkos P, Boucher M, Broussard PM, et al. Factors influencing nonstress test results in multiple gestations. Am J Obstet Gynecol 1986; 154:1107.</a></li><li><a class="nounderline abstract_t">Lodeiro JG, Vintzileos AM, Feinstein SJ, et al. Fetal biophysical profile in twin gestations. Obstet Gynecol 1986; 67:824.</a></li><li><a class="nounderline abstract_t">Booker W, Fox NS, Gupta S, et al. Antenatal Surveillance in Twin Pregnancies Using the Biophysical Profile. J Ultrasound Med 2015; 34:2071.</a></li><li><a class="nounderline abstract_t">Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231. Obstet Gynecol 2021; 137:e145.</a></li></ol></div><div id="topicVersionRevision">Topic 130561 Version 11.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895946" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895946" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35852802" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Association of Optimal Gestational Weight Gain Ranges With Perinatal Outcomes Across Body Mass Index Categories in Twin Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35852802" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Association of Optimal Gestational Weight Gain Ranges With Perinatal Outcomes Across Body Mass Index Categories in Twin Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34775675" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Gestational weight gain in twin gestations and pregnancy outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34044741" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Association between gestational weight gain and perinatal outcomes among twin gestations based on the 2009 Institute of Medicine (IOM) guidelines: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25166622" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The association of inadequate mid-pregnancy weight gain and preterm birth in twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20168116" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Optimal nutrition for improved twin pregnancy outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36379267" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Working conditions in women with multiple pregnancy-the impact on preterm birth and adherence to guidelines: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12193948" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Placental types and twin-twin transfusion syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15343200" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Monozygotic twins with discordant karyotypes: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10073913" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : 'Identical' twins with discordant karyotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8140071" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Identical twins with trisomy 21 discordant for exomphalos.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6461252" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Monozygotic twins discordant for trisomy 21.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21234973" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Monochorionic diamniotic twin gestations discordant for markedly enlarged nuchal translucency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27315788" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : MCDA twins with discordant malformations: submicroscopic chromosomal anomalies detected by chromosomal microarray analysis and clinical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27741202" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Observed Rate of Down Syndrome in Twin Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33016373" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23035860" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23595772" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22585317" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24357023" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31165549" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30977206" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33957658" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33460583" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37030426" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32804883" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20066674" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16626615" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Does a "vanishing twin" affect first-trimester biochemistry in Down syndrome risk assessment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12628267" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17904965" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : First-trimester risk assessment for trisomies 21 and 18 in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24916689" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27270878" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16170837" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37087836" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Comparison of international guidelines on the management of twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25932853" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The North American Fetal Therapy Network Consensus Statement: prenatal management of uncomplicated monochorionic gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6682384" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The value of twin surveys in the study of malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17429797" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Detection of chromosomal abnormalities, congenital abnormalities and transfusion syndrome in twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17957043" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prevalence of congenital heart defects in monochorionic/diamniotic twin gestations: a systematic literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18387962" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Congenital anomalies in twins: a register-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20663725" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Genetics and developmental pathology of twinning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32783284" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The concordance rate of non-chromosomal congenital malformations in twins based on zygosity: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25560113" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The North American Fetal Therapy Network consensus statement: prenatal surveillance of uncomplicated monochorionic gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24763516" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21138932" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risk of congenital heart defects associated with assisted reproductive technologies: a population-based evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27232926" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Congenital heart disease in twins: The contribution of type of conception and chorionicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20498466" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Is the rate of congenital heart defects detected by fetal echocardiography among pregnancies conceived by in vitro fertilization really increased?: a case-historical control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27846734" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Reproductive technologies and the risk of congenital heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22559061" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Reproductive technologies and the risk of birth defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27226023" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Assisted conception and the risk of CHD: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27226023" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Assisted conception and the risk of CHD: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26577371" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : ISUOG Practice Guidelines: role of ultrasound in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14749653" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15467528" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12439498" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Size-discordant twin pairs have higher perinatal mortality rates than nondiscordant pairs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14749655" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Neonatal mortality rates among growth-discordant twins, classified according to the birth weight of the smaller twin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14704247" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Is discordant growth in twins an independent risk factor for adverse neonatal outcome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12636964" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The effect of birth weight discordance on twin neonatal mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15625146" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Growth restriction as a determinant of outcome in preterm discordant twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12220766" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Fetal and neonatal mortality among twin gestations in the United States: the role of intrapair birth weight discordance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16170859" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Discordant growth in twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24338685" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Cerebral injury in monochorionic twins with selective intrauterine growth restriction: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9504230" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : What are the fetal growth patterns of singletons, twins, and triplets in the United States?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27143399" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Dichorionic twin trajectories: the NICHD Fetal Growth Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34416423" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Developmental outcomes in small-for-gestational age twins using a singleton vs twin birthweight reference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33771495" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Dichorionic twin-specific vs singleton growth references for diagnosis of fetal growth restriction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35114185" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Should twin-specific growth charts be used to assess fetal growth in twin pregnancies?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8590207" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Accuracy of ultrasound estimation of fetal weight in multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7900521" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prediction of fetal weights in twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8090383" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The sonographic assessment of twin growth discordancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5645958" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The Birmingham twin survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21691168" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Definition of intertwin birth weight discordance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23355123" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Weight discordance and perinatal mortality in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27171760" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Optimal threshold for birth weight discordance: Does knowledge of chorionicity matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30903624" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Birthweight discordance and neonatal morbidity in twin pregnancies: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33686672" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Ultrasound for diagnosis of birth weight discordance in twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11264601" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Twin pregnancy: the role of ultrasound in management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25154937" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Does early second-trimester sonography predict adverse perinatal outcomes in monochorionic diamniotic twin pregnancies?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21795485" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Second-trimester estimated fetal weight and discordance in twin pregnancies: association with fetal growth restriction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27804184" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Diagnostic accuracy of ultrasound in predicting birth-weight discordance in twin pregnancy: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10775993" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Prediction of discordant twins by real-time ultrasonography combined with umbilical artery velocimetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12798478" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The Doppler assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12548229" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20560948" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28153653" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Prenatal diagnosis and management of vasa previa in twin pregnancies: a case series and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33345868" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Vasa previa and associated risk factors: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28976606" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Significance of placental cord insertion site in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16969785" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Timely diagnosis of twin-to-twin transfusion syndrome in monochorionic twin pregnancies by biweekly sonography combined with patient instruction to report onset of symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23481221" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Placental characteristics in monochorionic twins with spontaneous versus post-laser twin anemia-polycythemia sequence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19375567" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The pregnancy and long-term neurodevelopmental outcome of monochorionic diamniotic twin gestations: a multicenter prospective cohort study from the first trimester onward.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14526320" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Antenatal factors associated with significant birth weight discordancy in twin gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16643828" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17761462" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Intrauterine growth restriction in monochorionic twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35667417" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Impact of placental sharing and large bidirectional anastomoses on birthweight discordance in monochorionic twins: a retrospective cohort study in 449 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18831073" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Intrauterine growth in multiple pregnancies in relation to fetal number, chorionicity and gestational age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10561633" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Positive predictive value of suspected growth aberration in twin gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26259909" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Dichorionic twin ultrasound surveillance: sonography every 4 weeks significantly underperforms sonography every 2 weeks: results of the Prospective Multicenter ESPRiT Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15971947" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : High risk of unexpected late fetal death in monochorionic twins despite intensive ultrasound surveillance: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3706440" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Factors influencing nonstress test results in multiple gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3517725" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Fetal biophysical profile in twin gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26453124" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Antenatal Surveillance in Twin Pregnancies Using the Biophysical Profile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34011891" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
